A 10 year old NM Golden Retriever was presented with a history of systemic hypertension, emerging pulmonary hypertension, and mitral insufficiency, which was being managed with 2.5 mg amlodipine once a day. A soft tissue sarcoma had been removed previously from the dog’s back. Arrhythmia, multiple soft movable subcutaneous masses, weight loss, and muscle wasting were noted on physical examination. Urinalysis was within normal limits. On CBC, thrombocytosis, lymphocytosis, and monocytosis were present. The only abnormality on serum biochemistry was elevated GGT activity.

A 10 year old NM Golden Retriever was presented with a history of systemic hypertension, emerging pulmonary hypertension, and mitral insufficiency, which was being managed with 2.5 mg amlodipine once a day. A soft tissue sarcoma had been removed previously from the dog’s back. Arrhythmia, multiple soft movable subcutaneous masses, weight loss, and muscle wasting were noted on physical examination. Urinalysis was within normal limits. On CBC, thrombocytosis, lymphocytosis, and monocytosis were present. The only abnormality on serum biochemistry was elevated GGT activity.